EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters

Yoshihiro Izumiya iD, Adhraa Algalil, Jonna M Espera, Hiroki Miura, Chie Izumiya, Tomoki Inagaki, Ashish Kumar

Journal of Virology · 2024

DOI: 10.1128/jvi.01386-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Yoshihiro Izumiya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California Davis, Sacramento, California, USA. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Immediate-Early Proteins, Sarcoma, Kaposi. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | NIH | National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhancers are a crucial regulator of differential gene expression programs. Enhancers are the cis-regulatory sequences determining target genes’ spatiotemporal and quantitative expression. Here, we show that Kaposi’s sarcoma-associated herpesvirus (KSHV) terminal repeats fulfill the enhancer definition for KSHV inducible gene promoters. The KSHV enhancer is occupied by latency-associated nuclear antigen (LANA) and its interacting proteins, such as CHD4. Neighboring terminal repeat (TR) fragments to lytic gene promoters drastically enhanced KSHV replication and transcription activator and LANA transcription regulatory functions. This study, thus, proposes a new latency–lytic switch model in which TR accessibility to the KSHV gene promoters regulates viral inducible gene expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanImmediate-Early ProteinsSarcoma, KaposiHumansHistonesNucleosomesVirus LatencyAntigens, ViralTerminal Repeat SequencesGene Expression Regulation, Viral

Stichwörter der Autor:innen

BRD4CHD4Kaposi's sarcoma-associated herpesvirusRNA polymerasesenhancerherpesviruseslatencyreactivationtranscriptional regulation

Substanzen

HistonesNucleosomesImmediate-Early ProteinsAntigens, Viral

Autor:innen und Institutionen

  • Department of Dermatology, School of Medicine, University of California Davis, Sacramento, California, USA.
  • Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, California, USA.
  • Midwestern University College of Dental Medicine, Glendale, Arizona, USA.

ORCID-Profile: Yoshihiro Izumiya

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | National Cancer Institute
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Izumiya, Y., Algalil, A., Espera, J. M., Miura, H., Izumiya, C., Inagaki, T., & Kumar, A. (2024). Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters. Journal of Virology. https://doi.org/10.1128/jvi.01386-23

Vancouver

Izumiya Y, Algalil A, Espera JM, Miura H, Izumiya C, Inagaki T, et al. Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters. Journal of Virology. 2024. doi:10.1128/jvi.01386-23

BibTeX
@article{Izumiya2024,
  author = {Izumiya, Yoshihiro and Algalil, Adhraa and Espera, Jonna M and Miura, Hiroki and Izumiya, Chie and Inagaki, Tomoki and Kumar, Ashish},
  title = {Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01386-23}
}
Kostenlos starten →